This topic contains a solution. Click here to go to the answer

Author Question: The most common organization scheme for neutral messages is _____. A) the say-it-then-do-it ... (Read 51 times)

jace

  • Hero Member
  • *****
  • Posts: 541
The most common organization scheme for neutral messages is _____.
 
  A) the say-it-then-do-it approach
  B) the inverted pyramid
  C) the message box
  D) Monroe's Motivated Sequence
  E) straight-forward approach

Question 2

Bad news is best presented in the _____ of a message.
 
  A) beginning
  B) middle
  C) end
  D) It doesn't make any difference. Bad news is bad news.
  E) This is a trick question: There is no best way to deliver bad news



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ricroger

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

Answer: B

Answer to Question 2

Answer: B




jace

  • Member
  • Posts: 541
Reply 2 on: Aug 11, 2018
Gracias!


aruss1303

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Thanks for the timely response, appreciate it

 

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

Vaccines prevent between 2.5 and 4 million deaths every year.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

By definition, when a medication is administered intravenously, its bioavailability is 100%.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

For a complete list of videos, visit our video library